Результаты поиска - David Devos

Отмена результатов
  1. 1
    Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease

    Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease по David Devos

    Опубликовано 2004
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics

    Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics по Alexandre Demailly, Caroline Moreau, David Devos

    Опубликовано 2024
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Seven Solutions for Neuroprotection in Parkinson's Disease

    Seven Solutions for Neuroprotection in Parkinson's Disease по David Devos, Étienne C. Hirsch, Richard Wyse

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    Regional siderosis: a new challenge for iron chelation therapy

    Regional siderosis: a new challenge for iron chelation therapy по Z. Ioav Cabantchik, Arnold Münnich, Moussa B. H. Youdim, David Devos

    Опубликовано 2013
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Early occurrence of inspiratory muscle weakness in Parkinson’s disease

    Early occurrence of inspiratory muscle weakness in Parkinson’s disease по Guillaume Baille, T. Pérez, David Devos, Valérie Deken, Luc Defebvre, Caroline Moreau

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

    Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration по Shashank Masaldan, Ashley I. Bush, David Devos, Anne‐Sophie Rolland, Caroline Moreau

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates

    Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates по Flore Gouel, Anne‐Sophie Rolland, Jean‐Christophe Devedjian, Thierry Burnouf, David Devos

    Опубликовано 2019
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  8. 8
    Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation

    Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation по David Devos, P. Jissendi Tchofo, I. Vuillaume, A. Destée, S. Batey, John Burn, Patrick F. Chinnery

    Опубликовано 2008
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  9. 9
    Dyspnea: An underestimated symptom in Parkinson's disease

    Dyspnea: An underestimated symptom in Parkinson's disease по Guillaume Baille, Cécile Chenivesse, T. Pérez, François Machuron, Kathy Dujardin, David Devos, Luc Defebvre, Caroline Moreau

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

    Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease по Laura Mahoney-Sánchez, Hind Bouchaoui, Scott Ayton, David Devos, James A. Duce, Jean-Christophe Devedjian

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease

    Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease по James A. Duce, Bruce X. Wong, Hannah Durham, Jean-Christophe Devedjian, David P. Smith, David Devos

    Опубликовано 2017
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    Glycosphingolipids and neuroinflammation in Parkinson’s disease

    Glycosphingolipids and neuroinflammation in Parkinson’s disease по Karim Bélarbi, Elodie Cuvelier, Marie-Amandine Bonte, Mazarine Desplanque, Bernard Gressier, David Devos, Marie‐Christine Chartier‐Harlin

    Опубликовано 2020
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    Ventilatory Dysfunction in Parkinson’s Disease

    Ventilatory Dysfunction in Parkinson’s Disease по Guillaume Baille, Anna Maria De Jesus, T. Pérez, David Devos, Kathy Dujardin, C. Monaca Charley, Luc Defebvre, Caroline Moreau

    Опубликовано 2016
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  14. 14
    ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons

    ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons по Hind Bouchaoui, Laura Mahoney-Sánchez, Guillaume Garçon, Olivier Berdeaux, L. Alleman, David Devos, James A. Duce, Jean-Christophe Devedjian

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study

    Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study по Hélène Blasco, Guillaume Garçon, Franck Patin, Charlotte Veyrat‐Durebex, Judith Boyer, David Devos, Patrick Vourc’h, Christian Andrés, Philippe Corcia

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review

    The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review по Guillaume Grolez, Caroline Moreau, Véronique Danel-Brunaud, Christine Delmaire, Renaud Lopes, Pierre Pradat, Mohamed Mounir El Mendili, Luc Defebvre, David Devos

    Опубликовано 2016
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  17. 17
    The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways

    The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways по Flore Gouel, Bruce Do Van, Ming‐Li Chou, Aurélie Jonneaux, Caroline Moreau, Régis Bordet, Thierry Burnouf, Jean‐Christophe Devedjian, David Devos

    Опубликовано 2016
    Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  18. 18
    Iron as a therapeutic target for Parkinson's disease

    Iron as a therapeutic target for Parkinson's disease по Caroline Moreau, James A. Duce, Olivier Rascol, Jean‐Christophe Devedjian, Daniela Berg, David T. Dexter, Zvi-Ioav Cabantchik, Ashley I. Bush, David Devos

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  19. 19
    Exhaustive, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS

    Exhaustive, ONE-YEAR FOLLOW-UP OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A LARGE, SINGLE-CENTER COHORT OF PARKINSONIAN PATIENTS по Mélissa Tir, David Devos, S. Blond, Gustavo Touzet, Nicolas Reyns, Alain Duhamel, Olivier Cottencin, Kathy Dujardin, F. Cassim, A. Destée, Luc Defebvre, Pierre Krystkowiak

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease по Per Odin, К. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

    Опубликовано 2018
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: